Asthma diagnosis and symptoms in an allergen immunotherapy trial treating grass pollen induced rhinoconjunctivitis

被引：0
|
作者：
Hviid-Vyff, Bjarke [1 ,2 ]
Schmid, Johannes Martin [1 ,2 ]
Hoffmann, Hans Jurgen [1 ,2 ]
机构：
[1] Aarhus Univ, Aarhus C, Denmark
[2] Aarhus Univ Hosp, Aarhus C, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA4749
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4749
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Effectiveness of Allergen Immunotherapy Depending on the Regimen on Rhinoconjunctivitis and Asthma Symptoms in Allergy to Grass Pollen.
    Bochenska-Marciniak, M.
    Tworek, D.
    Kupczyk, M.
    Bogacka, E.
    Kuprys-Lipinska, I.
    Kuna, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [2] Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis
    Ellis, Anne K.
    Frankish, Charles W.
    O'Hehir, Robyn E.
    Armstrong, Kristen
    Steacy, Lisa
    Larche, Mark
    Hafner, Roderick P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (02) : 486 - 496
  • [3] Motivating factors for the initiation of allergen immunotherapy in severe, grass-pollen-induced rhinoconjunctivitis
    David, M.
    Hut, M.
    Meyer, M.
    Capecce, M.
    Polderman, C.
    ALLERGY, 2011, 66 : 634 - 634
  • [4] Allergen immunotherapy treatment perception and satisfaction in patients with severe, grass-pollen-induced rhinoconjunctivitis
    van der Brempt, X.
    Ghosn, N.
    David, M.
    ALLERGY, 2012, 67 : 614 - 614
  • [5] Sublingual five-grass pollen tablets (Oralair®): A guide to their use as allergen immunotherapy for grass pollen-induced allergic rhinoconjunctivitis
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2014, 30 (6) : 200 - 208
  • [6] Allergen immunotherapy regimens and adherence in patients suffering from severe grass-pollen-induced rhinoconjunctivitis
    David, M.
    Hut, M.
    Meyer, M.
    Capecce, M.
    Polderman, C.
    ALLERGY, 2011, 66 : 634 - 635
  • [7] Efficacy and safety of subcutaneous immunotherapy with pollen allergen extracts in asthma and allergic rhinoconjunctivitis
    Laurrabaquio Miranda, A.
    Celio Murillo, R.
    Rodiguez Santos, O.
    Tinoco Moran, I. O.
    Abou Kahir, F.
    Cuevas Castillejos, H. U.
    Cruz Suarez, M. A.
    Cruz Marmolejo, M. A.
    ALLERGY, 2013, 68 : 547 - 547
  • [8] Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial
    Lima, MT
    Wilson, D
    Pitkin, L
    Roberts, A
    Nouri-Aria, K
    Jacobson, M
    Walker, S
    Durham, S
    CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (04): : 507 - 514
  • [9] Grass pollen immunotherapy (SLIT) for seasonal rhinoconjunctivitis: a randomised controlled trial
    Lima, MT
    Wilson, DR
    Pitkin, L
    Roberts, A
    Nouri-Aria, KT
    Jacobson, M
    Walker, SM
    Durham, SR
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (07): : 1158 - 1158
  • [10] Asthma prevention trial of an SQ-standardised grass allergy immunotherapy tablet for children with grass pollen-induced rhinoconjunctivitis: preliminary baseline characteristics
    Roberts, G.
    Berstad, A.
    de Blic, J.
    Bufe, A.
    Ebbesen, D.
    Eng, P.
    Halken, S.
    Laursen, M.
    Ojeda, P.
    Varga, E.
    Winnergard, I
    ALLERGY, 2012, 67 : 417 - 417
12345